COVID vaccination: 29 percent higher antibody response if more than 20 ng of vitamin D
Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine
Curr Res Transl Med. 2022 Mar 16 doi: 10.1016/j.retram.2022.103344
Isabelle Piec,1 Laura Cook,2 Samir Dervisevic,1,3 William D Fraser,1,2 Scott Ruetten,4 Marvin Berman,4 Emma English,1,2,⁎ and W Garry John1,2,⁎

Background
Most approved vaccines utilise a two-dose strategy. To enable larger groups of patients to receive the first dose, the UK government increased the gap between the two doses from three to twelve weeks. Here we report on the immunogenicity of the first dose, including effect of age and vitamin D status on these levels over an 8 week-period.
Methods
Blood samples were collected from healthcare workers (HCW) receiving their first BNT162b2 vaccine dose between January and February 2021. Antibody (Ab) production was measured, prior to and weekly for 4 weeks post immunization, and a final measurement was performed at 8 weeks. Serum vitamin D concentrations were also measured at baseline.
Findings
Immunization of 97 HCW induced an Ab response that peaked 3•2 weeks post immunization to decrease thereafter. Ab levels remained positive at 8 weeks. IgG peak concentration was negatively associated with age (β=-0•440, p<0.001). Response to immunization was also significantly affected by vitamin D status (p=0•022), on average 29•3% greater peak value in individuals with 25(OH)D>50nmol/L. No other variable showed significant effect.
Interpretation
The first dose of BNT162b2 produced Ab levels that remained positive after 8 weeks. Peak was greater in younger subjects and 25(OH)D>50nmol/L was beneficial. Booster campaigns should take into consideration vitamin D status which is at its highest following a period of sunshine exposure or following oral supplementation (400-1000IU daily).
📄 Download the PDF from VitaminDWiki
/Study reported at News Medical
Similar studies
Vitamin D3 replacement enhances antigen-specific immunity in older adults - Nov 2020 📄 PDF
See also VitaminDWiki
Influenza vaccine antibodies not change with Vitamin D – 21 ng or 44 ng – RCT Feb 2019
- Influenza and COVID vaccines seem to have opposite responses to Vitamin D
Vitamin D can probably augment or replace many vaccines – March 2015
7X less risk of influenza if Vitamin D levels higher than 30 ng – Oct 2017
Influenza prevented by 40 ng levels or treated with vitamin D hammer (50,000 IU) – June 2015
Number of people to treat to prevent 1 case of flu: Vitamin D 4, Vaccination 40 – Feb 2017
COVID, influenza, hepatitis B, measles, etc. vaccine responses vary with Vitamin D and its receptor